Johnson & Johnson (JNJ)

NYSE HEALTHCARE
$225.34 -0.95% RSI 43 Neutral Add Alert

Moving Averages

SMA 50
$239.69
Price below
SMA 200
$204.54
Price above
EMA 20
$233.87
Price below

Company Profile

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$547.64B
P/E Ratio
26.39
EPS
$8.62
Beta
0.329
Dividend Yield
2.25%
52-Week High
$251.71
52-Week Low
$142.16

Insider Transactions

ExecutiveTitleActionSharesDate
PINTO, DANIEL EDirectorBuy1292026-03-10
WOODS, EUGENE A.DirectorBuy1542026-03-10
HEWSON, MARILLYN ADirectorBuy2062026-03-10

Latest News

Earnings Call Transcript

Johnson & Johnson Q1 2026 — Hello, everyone. This is Darren Snellgrove, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the first quarter of 2026, and our financial outlook for the full year. First, a few logistics. As a reminder, today's presentation and associated schedules are available on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com. Please note that this presentation contains forward-looking statements regarding, among other things, the company's future operating and financial performance, market position and b…

Options Chain

TypeStrikeExpiryVolumeOpen Interest
Call$237.502026-04-241,264538
Call$260.002026-05-159413,653
Put$230.002026-04-24917713

Similar stocks in DRUG MANUFACTURERS - GENERAL

Data last updated: April 28, 2026 at 1:55 AM EDT

Track JNJ for free

Get e-mail RSI alerts when Johnson & Johnson enters oversold or overbought territory. Free forever.

Add Alert